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According to a recent study [1], peer-reviewed publications in
the field of medical and health sciences amounted to 12,796,558
in the period from 1980 to 2012, and currently are growing at rates
of 8–9% per year. This huge body of scientific literature is usually
interpreted in line with established paradigms that provide ratio-
nales, and guidance for future research. Paradigms are helpful,
but also have a great inertia, and lack of flexibility when facing
research results conflicting with their axiologies. Therefore,
research results can be found in all fields that were misinterpreted,
overlooked, or even discarded due to lack of explanation in the
context of existing paradigms. This is also true in the field cardio-
vascular diseases. Additionally, due to the current fast publication
rate, and the need to keep up-to-date with mainstream lines of
research, researchers almost exclusively take into consideration
the most recent literature, not paying much attention to older
results. However, the results that conflict with current paradigms
are of utmost importance, because they may trigger new ways of
thinking, redirect research priorities, and open new ways to the
solution of old problems.
In short: the current paradigm of etiology of cardiovascular dis-
eases [2] is based on two fundamental assumptions: (i) damage to
endothelium of blood vessels causes lesions, local inflammation
with mobilization of white blood cells, lipoproteins and other sub-
stances, which lead to development of fibrofatty atherosclerotic
plaques, thereby causing narrowing of arteries (stenosis or closureof the lumen); (ii) rupture of the atherosclerotic plaque with clot
formation may lead to arterial occlusion thereby stopping blood
flow (and oxygen) to a part of the heart causing damage to the
heart muscle (myocardial infarction) or to a part of the brain
(thromboembolic stroke).
Below we list some features of cardiovascular diseases picked
from a review by Baroldi and Silver [3] that hardly find a rationale
within the current paradigm of etiology of cardiovascular diseases:
– An occlusive coronary thrombus was found in about half of
infarct cases and in a minority of sudden/unexpected death
cases;
– In contrast to spleen, kidney, brain, etc, where cholesterol
emboli are often seen, in more than 14,000 myocardial sections
of all groups, only one atheromatous embolus was found in a
small intramural arteriole;
– Infarct size did not correlate with the number or degree and
length of severe stenoses present in the whole coronary arterial
system;
– It must be noted that in 37% of our cases, an infarct involved the
adjacent vascular territories of vessels that were not occluded;
– The presence of acute or organized thrombotic coronary occlu-
sion without a related infarct;
– In people that die accidentally from carbon monoxide intoxica-
tion, the acute hypoxia results in myocardial cell relaxation
without any other change (vacuolization, edema, pathological
contraction bands, etc);
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who died from accident but had no ischemic heart disease clin-
ically, nor any significant myocardial fibrosis;
– A higher frequency of sudden death in patients with a resting
heart rate P65 beats per minute (indicating low parasympa-
thetic activity) vs. 665 beats without relation with other risk
factors;
– An assumption proved is that normal subjects who undergo
surgical ligation of a lacerated coronary artery following a chest
wound do not develop a myocardial infarction.
In what follows we propose an explanatory framework for the
main aspects of cardiovascular diseases, and namely the facts
reported above, by taking into consideration the literature pub-
lished from the beginning of the sixties of the last century until
the present time.
The hypothesis
We put forward the following hypothesis:
(i) Cardiovascular diseases are the result of persistent states of
acidemia, paralleled with peaks of blood concentration of
free fatty acids (FFA);
(ii) Spikes in FFA concentration due to enhanced catabolic
imbalance of lipids, in a context of local (compensatory) pul-
monary alkalosis originate formation of FFA micelles, which
travel to the heart where due to local blood acidity they
transform into FFA vesicles with an acidic core;
(iii) FFA vesicles easily fuse with the membranes of the endothe-
lial cells then liberating the acidic core, which impairs local
ion transport (namely Ca2+) and damage the endocardium
and the endothelia of the aorta and nearby arteries;
(iv) Development of the resulting local inflammation, with
mobilization of clotting factors, immune system, and repair
processes, in which LDL particles and endothelial progenitor
cells (EPC) play an important role, results in plaque
formation;
(v) Acute crises such as myocardial infarction or stroke result
from increased local blood acidity that impairs calcium,
sodium and potassium ion exchange (among others), and
promote clotting factors and therefore thrombus and clot
formation within the blood stream, and in the damaged
epithelia at the sites most affected by vesicle adhesion.
In what follows we provide and discuss the many evidences
from the abundant biomedical literature that support the
hypothesis.
Blood acidemia
Acidemia occurs when blood pH drops below 7.35. The most
important causes of blood acidemia are [4–6]:
(I) Elevated cortisol levels, mainly due to chronic stress, though
other hormones such as epinephrine, norepinephrine, ghre-
lin, growth hormone, testosterone, may further contribute to
increase acidemia [6]. All these hormones increase lipopro-
tein lipase activity, therefore promoting lipolysis in the adi-
pose tissue and release of FFA into the blood, some of which
are taken up by cells. FFA not taken up by cells bind to albu-
min, which has 3 sites available for this purpose. When albu-
min binding sites are saturated, FFA accumulate in the blood,
thereby lowering blood pH. The liver takes up FFA from the
blood, and esterifies them (namely long-chain FA) to formtriglycerides that are incorporated into very low density
lipoproteins (VLDL), which are then released into the blood.
Little by little, cells absorb triglycerides from VLDL particles,
which turn into intermediate density lipoproteins (IDL), and
then into low density lipoproteins (LDL) when cholesterol
content surpasses that of triglycerides [6]. Spikes of blood
FFA concentration may occur as a sudden increase of sympa-
thetic activity, namely adrenergic shocks that boost lipolytic
activity.
(II) Metabolic acidosis due namely to chronic kidney disease
(CKD) which leads to reduction in serum bicarbonate (HCO3)
concentration. Metabolic acidosis develops when the kid-
neys are not removing enough acid from the body, as it hap-
pens with CKD. In fact, decrease in renal ammonium
excretion and a positive acid balance that may lower serum
bicarbonate concentration are observed in the course of CKD
[7–9].
(III) Drug-induced metabolic acidosis, which occurs when drugs
disrupt acid–base equilibrium. This effect may occur by
two means [10,11]: (a) Drug-related metabolic acidosis
owing to an increased H+ load, such as Biguanides, Antiretro-
viral Therapy, Linezolid, Isoniazid, Propylene Glycol, Propo-
fol, Adrenergic Stimulants, Nalidixic Acid, HMG-CoA
Reductase Inhibitors (Statins), Antipsychotic Agents, and
ingestion of Alcohols (Ethanol and Methanol), Ethylene Gly-
col, and other compounds; (b) Drug-related metabolic acido-
sis Due to HCO3 loss (Carbonic Anhydrase Inhibitors,
Ifosfamide, and other compounds). Metformin, which is
the most prescribed antidiabetic drug in the world, has been
associated with acidosis [12], and severe acidosis leading to
acute ST-elevation myocardial infarction [13].
(IV) Hypoventilation leading to high blood levels of CO2 (hyper-
capnia), which produces carbonic acid (respiratory acidosis).
It occurs when ventilation is insufficient to perform both
oxygen uptake and carbon dioxide discharge by the lungs
[14].
Acute blood acidemia and cardiovascular events
Hyperventilation as a compensatory mechanism to restore normal pH
levels
When blood pH drops below 7.35 some compensatory mecha-
nisms develop to restore normal pH levels. One such mechanism
is hyperventilation, which consists in increased alveolar ventila-
tion that leads to excess of carbon dioxide removal from the blood
stream in relation to that the body can produce, therefore turning
blood less acidic [15,16]. In a state of acidemia this is a compen-
satory mechanism for raising blood pH. It is very rapid and effec-
tive for this purpose because the enzyme carbonic anhydrase
catalyzes the rapid interconversion of blood bicarbonate and pro-
tons to carbon dioxide and water [17]. Other mechanisms concur-
rent to the same objective are removal of volatile acids by the lungs
through expiration, and removal of acids in the sweat, urine and
feces [18].
Rapid and relatively shallow breathing (shortness of breath) is
characteristic of mild up to high hyperventilation when blood acid-
emia has not reached extreme values, case in which it shifts to
Kussmaul breathing [19]. Due to trade-off between local (respira-
tory) alkalemia and the sympathetic activity, pulmonary vasocon-
striction occurs during hyperventilation [31]. Because
hyperventilation is as a compensatory mechanism to restore nor-
mal blood pH in the whole body, it keeps on eliminating CO2 in
the alveoli despite alveolar blood pH may have reached values
characteristic of alkalemia [20]. In such case, it is likely that blood
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monary veins.
Because binding of calcium to proteins increases with pH, it dis-
places fatty acids (FA) from albumin binding sites, which leads to
lowering of free calcium levels in the blood together with
increased concentration of FFA. Additionally, due to Bohr–Haldane
effect, the high pH locally enhances affinity of hemoglobin to oxy-
gen, and for that reason blood entering the left atria is close to the
oxygen saturation point.
At low pH fatty acids are fully protonated and form an oil phase,
while at high pH they are fully deprotonated and form FFA micelles
[21–24]. Micelle formation rate is strongly increased when blood
flow becomes turbulent, as it is well known that shaking promote
rapid micelle formation [24].
Mild endothelial activation and atherosclerosis
As explained above, hyperventilation, as a compensatory mech-
anism to restore normal blood pH levels in the whole blood,
induces local pulmonary alkalosis that entails significant changes
in the properties of the blood flowing from the lungs to the left
atrium of the heart. Therefore, blood entering the left atrium must
have a high pH, low free calcium (due to high albumin binding
affinity) increased FFA content, hemoglobin close to the oxygen
saturation point, and contain FA micelles.
Blood flow into the left atrium is highly turbulent and, together
with high FFA concentration, creates the conditions to accelerate
FA micelle formation. On the other hand, blood pH is maximal at
the alveoli and decreases downstream as it comes into contact
with tissues with lower pH. This aspect induces new transforma-
tions in the blood as if flows within the heart and downstream:
(a) Blood coming from the lungs as a fatty acid micellar solution
shifting to lower pH spontaneously generates vesicles with a
broad size distribution [26]. FFA vesicles are formed by FA in
such a way that the hydrophilic ‘‘head” is in contact with
surrounding blood while the hydrophobic single-tail region
points to the micelle center. Because of the pH partition
effect, vesicles formed in alkaline conditions are likely to
have an acidic core, due to deprotonation of FA [21–23,25–
27].
(b) Number of FA vesicles can increase exponentially, because
they grow spontaneously when alkaline micelles are added
to already existing vesicles. Spontaneous assembly of FA
vesicles from alkaline micelles diluted into buffered solution
is an autocatalytic process [28].
(c) Partial pressure of oxygen progressively increases, therefore
enhancing concentration of ion superoxide (O2) and reactive
oxygen species (ROS), which easily forms in highly oxy-
genated blood environment [28,29];
(d) Free calcium ion concentration increases due to progressive
loss of affinity to albumin with decreasing pH.
(e) Pulmonary vasodilatation is directly favored by local alka-
lemia, while systemic acidemia favors vasodilatation of the
peripheral arteries [30]. However direct vasodilatation is off-
set by the indirect sympathetically mediated vasoconstric-
tion and cardiac stimulation during mild acidosis [31].
The consequences of such transformation in the blood are the
activation of the endocardium, and the endothelia of the arteries
that first receive the blood ejected from the left ventricle: the coro-
nary arteries, the aorta, and the nearby distributaries (brachial, car-
otids, subclavian, hepatic, gastric).
Fatty acid vesicles are supramolecular structures, in which the
molecular components are in rapid dynamic equilibrium with the
surrounding solution and with each other [25]. Because of thisfeature together with the high affinity between the FA vesicle
membranes and cell membranes they easily fuse with endothelial
cells, thereby delivering them the acidic core. Alternatively,
because protons can pass through some membranes they can deli-
ver the acidic core by diffusion rather than by direct fusion with
the cells [32]. The result is a marked increase in the local acidity
at the sites where FA vesicles attach to the endothelium, which dis-
rupts many important ion exchange processes, namely trafficking
of Ca2+, K+, and Na+ [33]. These ions control vital cell processes,
and namely calcium ions control contractibility of smooth muscle
in the arteries [6], and also of the myocardium as it is known that
this muscle is also controlled by the endocardium [34].
Local acidity also strongly reduces binding affinity of albumin to
calcium ions which are released at the sites where FA vesicles
attach to endothelium, and react with acids to form calcium salts,
and other calcium derived molecules. This partially explains artery
calcification.
Local acidity also reduces affinity of hemoglobin to oxygen
(Bohr–Haldane effect [35]), therefore strongly increasing local pro-
duction of ion superoxide (and other ROS), which is toxic to
endothelial cells in the absence of adequate levels of the various
superoxide dismutase enzymes (SODs) [36].
As a consequence, endothelial cells at the vesicle attachment
sites become damaged or die, hence liberating cytokines that
mobilize both the immune and repair systems to the affected site.
The result is endothelial remodeling, which entails plaque forma-
tion (see Section Thromboembolic stroke below).
Attachment of vesicles occurs at sites where flow shear stresses
are minimal, because they correspond to minimal entrainment in
the blood stream (minimal lift force). This is made clear in the map-
ping of arterial plaque distribution [37]. This aspect also explains
why plaques develop at preferred sites rather than being distributed
uniformly on the inner artery wall. Not surprisingly, plaque compo-
sition includes ‘‘incrustation around individual microvesicles of
lipids eventually coalescing to larger clumps of calcification” [38].
If this process keeps developing at low intensity for years, it
may promote progressive arterial calcification, with growing num-
ber of plaques of increasing dimension covering the inner surface
of affected arteries. The fact that arteries most affected by calcifica-
tion are just those that receive the altered blood ejected from the
left ventricle (the coronaries, aorta, and the carotids) [37] adds
credit to the process above described.
Heart attack
When spikes of FFA occur in a context of acidemia, exception-
ally strong activation of the endocardium and the endothelia of
the arteries may occur. We stress again that spontaneous forma-
tion of FA vesicles from alkaline micelles is an autocatalytic process
[25]. Hence when FFA concentration peaks to high values we must
expect a stormy development of FA vesicles in the left atrium and
ventricle together with very intense and acute activation of the
endocardium and endothelium, namely in the coronaries, the
aorta, and the carotids.
If endocardium in the left atrium and ventricle is severely dam-
aged, the myocardial function is also compromised in what
respects to contractibility and electric activity [39]. Due to local
acidemia the coronaries constrict, hence lowering blood flow into
the myocardium [31]. Additionally, severe local acidemia due to
high FA vesicle concentration sharply decreases affinity of hemo-
globin to oxygen, which is released into the blood, then promoting
formation of ion superoxide and ROS in the acidic blood stream
that feeds the myocardium. In regions perfused by this toxic blood
with low pH, and carrying FA vesicles together high concentration
of ion superoxide and ROS, myocardial cells might die (Contraction
Band Necrosis – CBN), albeit oxygen is available locally. This might
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almost normal levels in the myocardium [3]. It explains also how
ischemia can develop albeit no thrombus is found blocking the
coronary arteries [3]. In the present context the extent of myocar-
dial ischemia depends both upon the extent of the region bathed
by the toxic blood and the ability of the cardiac veins to collect
and return blood to the right atrium through the coronary sinus.
We speculate that toxic FFA vesicles might be responsible for
myocardial CBN, by rupturing sarcolemma, the cell membrane of
the myocardium striated muscle fiber cell. In fact, at the sites
where FFA vesicles release their acidic core, an acidic spot must
be created that decreases calcium binding affinity to albumin,
and thereby high free calcium levels are likely to be present at
these sites. By quoting [40]: ‘‘massive Ca2+ entry from the plasma
reperfusing the tissue (causes) an enormous cell swelling, contrac-
tion bands, and mitochondrial hydroxyapatite accumulation. Thus,
the mitochondria of myocytes reperfused early in the phase of irre-
versible injury exhibit significant energy-linked function manifest
by the accumulation and deposition of calcium phosphate. After
reperfusion, such mitochondria could open the mitochondrial per-
meability transition pore, thereby releasing some of the accumu-
lated Ca2+ and accelerating cellular disintegration”. As noted by
known cardiologists: ‘‘in other specific diseases where CBN is
found, an adrenergic stress is part of their natural history” [3].
Differences between heart attack and mild endothelial activa-
tion is only a matter of intensity. Due to the stormy development
of FA vesicles that is thought occur during a heart attack they are
most likely formed at higher degree within the left atrium and ven-
tricle, while during mild endothelial activation they are likely
formed within the nearby arteries, and in lesser degree.
Despite the above process might explain ischemia development
without arterial occlusion, thrombi may be concomitantly formed
as the consequence of activation of prothrombotic factors (see Sec-
tion Thromboembolic stroke) and then block the coronaries. In
such a case, hypoxia leads to pyruvate formation from conversion
of glucose, or fatty acids (through a reaction with acetyl-CoA). Lac-
tate is then produced from the pyruvate faster than the body can
process it, causing lactate concentrations to go up, therefore
explaining why acid lactic is found in the myocardium in many
cases of heart attack [41].
Here a question remains: Why a state of acidosis (and blood
acidemia) is not always followed by heart attack? We remark that
acidosis/acidemia originates from various factors, and may develop
at low levels of FFA, though FFA must be present in adequate con-
centration in the blood for micelles and then vesicles to form. This
aspect points to the essential role of FA metabolism, namely the
hormones that promote lipolysis and discharge of FFA into the
blood. As referred before the liver takes up FFA from the blood
esterifies and releases them into the blood packaged as triglyc-
erides into VLDL particles. Therefore, concentrations of VLDL and
triglycerides in the blood are markers of FFA trafficking and may
be viewed as surrogates of blood FA concentration in the blood.
Long ago, blood levels of VLDL and triglycerides have been consid-
ered as risk factors for cardiovascular diseases. Yet, in the above
framework, blood levels of VLDL and triglycerides (as surrogates
for FFA level), only become dangerous if superimposed to acidemia.
Finally, we remark that the clinical symptoms of acidemia and
of heart attack have much in common [42]. All the main symptoms
of heart attack are easily understood in the framework developed
above:
(a) ‘‘Chest discomfort or pain (feel like a tight ache, pressure,
fullness or squeezing in the chest); Pain or discomfort may
spread beyond the chest to the shoulders, arms, back, neck,
teeth or jaw; Pain or discomfort may spread beyond the
chest to the shoulders, arms, back, neck, teeth or jaw; Painmay extend downward into the abdominal area. Nausea
and vomiting”. The symptoms perfectly match development
of micelles and vesicles, attachment and damage to endo-
cardium and the endothelia of arteries of the heart (damage
to myocardium), chest and arms, the whole aorta and upper
distributaries (pain in the back, neck, teeth or jaw), lower
distributaries (nausea and vomiting), which are bathed by
toxic blood with FA vesicles, superoxide ions, and ROS
ejected from the left ventricle.
(b) ‘‘Shortness of breath (patients may pant for breath or try to
take in deep breaths)”. This symptom is characteristic of aci-
dosis/acidemia, and it is worth noting that ‘‘try to take in
deep breaths” (Kussmaul breathing) is characteristic of sev-
ere acidemia;
(c) ‘‘Lightheadedness” appears as the result of vasoconstriction
of arteries in the brain due to acidemia;
(d) ‘‘Anxiety” as the result of activation of the sympathetic sys-
tem facing a threat to whole body;
(e) ‘‘Excessive sweating” as a means for the body to get rid of
excess acid.
Additionally it is well known that people that suffered heart
attack often felt tired in the days before. This may be a symptom
of developing acidemia since muscle fatigue comes with acidemia
because ‘‘intracellular acidosis affects many aspects of muscle cell
function; for instance it reduces maximal Ca2+activated force and
Ca2+ sensitivity, slows the maximal shortening velocity and pro-
longs relaxation” [43].
Thromboembolic stroke
It is well established that thromboembolic stroke is caused by
occlusion of an artery in the brain either by a locally formed throm-
bus or by an embolus generated elsewhere upstream. From now on
we use the term clot as a general designation for both thrombus
and embolus. The simplest definition of clots is that they are com-
posed of platelet aggregates in a mesh of fibrin, which includes also
other components (macrophages, foam cells) [44].
There is a huge body of literature dealing with clot formation
[45]. The actual paradigm of clot formation relies on the activation
of atherosclerotic plaques by factors present in the blood, which
produce an inflammatory state in the course of which clot is
formed and released into the blood stream. In what follows we pre-
sent another process by which clots may be formed.
Emboli most usually arise from the heart especially during
atrial fibrillation events [46,47]. It is not difficult to understand clot
formation within the present framework. The abnormal heart
rhythm with rapid and irregular beating that is characteristic of
atrial fibrillation strongly shakes the blood within the left atrium
and ventricle hence creating the conditions propitious to FA vesicle
formation, in case of adequate level of FFA [21,23,24]. FA vesicles
are not clots, because not only their composition is very different
but also because they are very small and not likely to reach dimen-
sion characteristic to clots. However, because they are clusters of
FA, they have the ability to activate blood coagulation factors,
namely Factor VII (Hageman Factor) and Factor XII. This aspect
has been observed more than fifty years ago [48–54]. At the epoch
it was found that ‘‘concentrations of soaps comparable to the con-
centration of free fatty acids found in human plasma shorten the
recalcified clotting time and accelerate the formation of artificial
thrombi in vitro the clot-promoting properties of the soaps of
long-chain saturated fatty acids” [53]. Connor and Poole demon-
strated that ‘‘sodium soaps of long-chain saturated fatty acids dra-
matically accelerated the recalcified clotting time of whole blood in
silicone-coated tubes or in rotating plastic loops”. Additionally, it is
of great significance that it was referred that: ‘‘the data presented
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kely to be significant under the conditions present in circulating
blood”. From the above quotations it is also of note that rotating
plastic loops dramatically accelerated clotting. Actually, as referred
above, FFA soaps are micellar solutions that when strongly shacked
rapidly form FA vesicles. Also of note is the reference to the fact
that under the conditions present in circulating blood it is unlikely
the formation of blood clots. Interestingly, it was also observed
that there was a rapid net uptake of FFA by human platelets when
long-chain FFA, bound to human serum albumin were incubated
with platelet suspensions [55], and that platelet aggregation
promoted by long-chain saturated FA is only observed when the
molar ratio FFA/albumin is greater than 2 [56], therefore confirm-
ing that a high blood FFA level is required to induce platelet
aggregation.
These features add credit to the idea that clots may form
through activation of blood coagulation by FA vesicles, and there-
fore they have to be present in the blood prior to clot development.
Though the research line on the link between FFA soaps and
blood coagulation seems to have been discontinued towards the
end of the sixties of the last century, many references on other
aspects of such link continued to appear in later published litera-
ture. Elevated plasma FFA levels also favor thromboxane formation
[57], vasoconstriction (though not all FFA do it at the same degree)
[58,59], significantly elevate lipoprotein(a) [60], activate plasmino-
gen activator inhibitor-1 (PAI-1) [61,62], and the coagulation fac-
tors VII and XII [63,64].
All those FFA effects create the appropriate explanatory context
for considering FFA vesicles as the precursors (and probably the
core) of clot formation. Concomitantly all the above-mentioned
aspects are consensually considered risk factors for clot formation.
The common link is elevated blood FFA level. In this sense, serum
VLDL levels should be viewed as a surrogate marker of a state of
elevated blood FFA level. Risk of acute crises (heart attack, throm-
boembolic stroke) may be very high when spikes of FFA are super-
imposed to acidemia. Therefore, periodic checking of blood levels
of FFA is of most clinical relevance.Additional remarks
Damage to endothelium starts repair processes that involve
clotting factors such as PA1-I, fibrin, lipoprotein(a), collagen pre-
cursors, among others, the immune system (white blood cells,
cytokines, and other mediators) and lipoproteins (mainly LDL,
and HDL) carrying several molecules, namely esterified and unes-
terified cholesterol . Inflammation is characteristic of the whole
process, which leads to formation of atheromatous plaques mainly
composed of fat, cholesterol, and calcified deposits, collagen, and
elastin. Endothelial progenitor cells that are multiple different cell
types circulating in the blood [65], are attracted to the lesion, and
play various roles in the regeneration of the endothelium. As the
result, severe narrowing of arteries may occur, thereby limiting
blood flow. The actual paradigm of formation of atherosclerotic
plaques assigns to cholesterol a major role, and abundant related
literature may be found elsewhere, e.g. [66].
Though the process here proposed for clot development does
not assign such role to cholesterol, it does not exclude the possibil-
ity of atheromatous clots to be also originated by occasional rup-
ture of unstable plaques. Instead, in the proposed scheme plaque
formation is the result of the same process that originates clots
with vesicle cores, which also involves attachment of FFA vesicles
to the endothelium and subsequent inflammation. This process of
endothelial activation might be active in other arterial diseases.
The huge amount of observational data collected in the last
hundred years enabled the identification of panoply of biomarkersthat may be associated with cardiovascular diseases. If the associ-
ation is statistically significant they are termed ‘‘risk factors”. How-
ever, because association does not mean causation we do need to
identify the real drivers of the main processes that lead to estab-
lishment of disease. Therefore a hierarchy must be established
amongst risk factors such as to differentiate the respective role in
the process. In the scheme here proposed, persistent blood acide-
mia together with high blood levels of FFA is the driver of
atherosclerosis, while spikes of FFA superimposed to acidemia is
the driver of acute crises, namely of heart attack and thromboem-
bolic stroke. The remaining risk factors appear either as partici-
pants or facilitators of the process, or as collateral ‘‘imprints” left
on blood composition (biomarkers), or the endothelium. VLDL par-
ticles, triglycerides, albumin, lipoprotein (a), plasminogen activator
inhibitor-1, fibrin, and the coagulation factors VII and XII are exam-
ples of participants/facilitators. Inflammations, calcified vesicles,
calcium salts, and other arterial deposits are ‘‘imprints” of the
ongoing process that might end with an acute crisis.
This hierarchy is fundamental for the design of clinical trials,
because in case of the target selected for testing its influence on
some end-point, is a minor participant/facilitator of the process it
is likely that the trials ends with deceptive results. Unfortunately,
so far no major trial has addressed the role of FFA in cardiovascular
disease.
The explanatory framework proposed here appears only as a
starting point, and is not intended to tell the whole history of car-
diovascular disease, although it aims at opening a new way to look
at a very complex problem whose full understanding remains
somehow elusive.
Conclusions
The hypothesis that prolonged acidemia with high blood levels
of free fatty acids shapes the basic context for formation of fatty
acid micelles and vesicles with an acidic core that fuse with the
endothelia is substantiated both from the side of biomedical
research, and the side of medical literature. It offers a comprehen-
sive explanation of many known features of cardiovascular dis-
eases. As a first step for an alternative view of cardiovascular
diseases it requires further developments.
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